Maculopapular rash associated with risperidone in a child

IF 0.5 4区医学 Q4 PHARMACOLOGY & PHARMACY

Psychiatry and Clinical Psychopharmacology Pub Date : 2019-10-02 DOI:10.1080/24750573.2018.1468639

H. Güler, S. Türkoğlu, D. Güler

引用次数: 2

Abstract

ABSTRACT Risperidone is an atypical antipsychotic that antagonizes 5HT2A and D2 receptors. Risperidone is used for many indications in children and adolescents. These indications include bipolar mania, schizophrenia, disruptive behaviour disorders, and aggression associated with autism spectrum disorder/mental retardation. Although it is usually well tolerated, weight gain, somnolence, rhinitis, headache, and rising appetite are among the most noticed side effects. Here we present a 5-year-old boy who developed diffuse nonpruritic maculopapular skin rash with a stable dosage of risperidone in the eighth month of treatment.

查看原文本刊更多论文

儿童与利培酮相关的丘疹

利培酮是一种非典型抗精神病药，可拮抗5HT2A和D2受体。利培酮用于儿童和青少年的许多适应症。这些适应症包括双相躁狂症、精神分裂症、破坏性行为障碍和与自闭症谱系障碍/智力迟钝相关的攻击行为。虽然通常耐受性良好，但体重增加、嗜睡、鼻炎、头痛和食欲上升是最值得注意的副作用。在这里，我们提出了一个5岁的男孩谁发展弥漫性非瘙痒性斑疹丘疹与稳定剂量的利培酮治疗的第8个月。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Psychiatry and Clinical Psychopharmacology Medicine-Psychiatry and Mental Health

CiteScore

1.00

自引率

14.30%

发文量

期刊介绍： Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.